Blog

John J Collins: Understanding Pancreatic Cancer – Genetics, Early Action and Future Research

MedInsights Unleashed/LinkedIn

Apr 3, 2025, 22:44

John J Collins: Understanding Pancreatic Cancer – Genetics, Early Action and Future Research

John J Collins, CO-Founder at MedInsights Unleashed, shared a post by MedInsights Unleashed, on LinkedIn:

“New Episode: Understanding Pancreatic Cancer: Genetics, Early Action and Future Research

It was a great pleasure to have Professor Philip Agop, to discuss one of the most challenging cancers – pancreatic cancer. Professor Philip shares insights into early symptoms of pancreatic cancer such as chronic abdominal discomfort, abdominal pain, and unexplained weight loss. He also highlights that one of the earliest signs of localized pancreatic cancer can be yellowing of the eyes (jaundice), often accompanied by dark urine.

We also explore the role of genetics in pancreatic cancer, how a small proportion of patients may carry mutations like BRCA or KRAS, sometimes unknowingly, and why understanding family history is essential for assessing personal risk. Whether you’re a healthcare provider, caregiver, or patient, this conversation offers clarity, hope, and the latest thinking on early detection and research in pancreatic cancer.

For more details on this episode please see the primary posting below.

This episode is for informational purposes only and not a substitute for medical advice. Always consult your healthcare provider for personal guidance.

Thank you as always for your support,

Kind regards,

John.”

Quoting MedInsights Unleashed‘s post:

“New Podcast Episode
Understanding Pancreatic Cancer: Genetics, Early Action and Future Research

We’re pleased to welcome Professor Philip Agop, Professor of Medical Oncology at Wayne State University and the Henry Ford Cancer Institute, to MedInsights Unleashed. In this important episode, he shares critical insights into the detection and treatment of pancreatic cancer, one of the most challenging cancers in oncology.

Key Takeaways:

Why Early Diagnosis Is So Difficult
Pancreatic cancer often lacks clear early symptoms and routine screening, contributing to delayed diagnoses.
The Role of Genetics
Mutations in BRCA and KRAS genes and family history can significantly increase risk. Genetic testing plays a key role in identifying high-risk individuals.
Treatment Innovations
Neoadjuvant chemotherapy and targeted therapies, especially those focusing on KRAS mutations, are shaping the future of pancreatic cancer care.
Multidisciplinary Tumor Boards
Collaboration between oncologists, surgeons, nurses and radiologists is essential for developing personalized treatment strategies.
Growing Hope
Despite its challenges, pancreatic cancer research is evolving bringing new hope for improved outcomes.

Listen here.

Repost this episode it may help someone you know!

Reminder: This podcast is for informational purposes only and should not be considered medical advice. Please consult your healthcare provider for personalized guidance.

Are you a medical professional with a passionate topic? If you’d like to donate your time for an episode, reach out to us!

Thank you for supporting MedInsights Unleashed. Let’s keep building a community where patients, caregivers, and professionals stay informed, empowered, and inspired.”

Pancreatic Cancer